Abstract
Background
The entomopathogenic fungus Beauveria bassiana has been widely used to kill mosquito larvae and adults in the laboratory and field. However, its slow action of killing has hampered its widespread application. In our study, the B. bassiana fungus was genetically modified to express the Bacillus thuringiensis (Bt) toxin Cyt2Ba to improve its efficacy in killing mosquitoes.
Methodology/Principal findings
The efficacy of the wild type (WT) of B. bassiana and a transgenic strain expressing Cyt2Ba toxin (Bb-Cyt2Ba) was evaluated against larval and adult Aedes mosquitoes (Aedes aegypti and Aedes albopictus) using insect bioassays. The Bb-Cyt2Ba displayed increased virulence against larval and adult Aedes mosquitoes compared with the WT: for Ae. aegypti adults, the median lethal time (LT50) was decreased by 33% at the concentration of 1× 108 conidia/ml, 19% at 1× 107 conidia/ml and 47% at 1× 106 conidia/ml. The LT50 for Ae. albopictus adults was reduced by 20%, 23% and 29% at the same concentrations, respectively. The LT50 for Ae. aegypti larvae was decreased by 42% at 1× 107 conidia/ml and 25% at 1× 106 conidia/ml, and that for Ae. albopictus larvae was reduced by 33% and 31% at the same concentrations, respectively. In addition, infection with Bb-Cyt2Ba resulted in a dramatic reduction in the fecundity of Aedes mosquitoes.
Conclusions/Significance
In conclusion, our study demonstrated that the virulence of B. bassiana against mosquitoes can be significantly improved by introducing the Bt toxin gene Cyt2Ba into the genome to express the exogenous toxin in the fungus. The transgenic strain Bb-Cyt2Ba significantly reduced the survival and fecundity of Ae. aegypti and Ae. albopictus compared with the WT strain, which suggested that this recombinant B. bassiana has great potential for use in mosquito control.
Author summary
Mosquito vectors transmit many diseases to humans and animals, causing illness and death and resulting in substantial socio-economic burdens in endemic countries. The control of mosquitoes has almost exclusively relied on the use of chemical insecticides, which has recently led to the broad resistance of important mosquito vectors worldwide. Entomopathogenic fungi, such as Beauveria bassiana, are an important alternative or complement to chemical insecticides. However, the relatively slow action of fungal pathogens in killing mosquitoes, compared with chemical insecticides, has hampered their widespread application. To improve the insecticidal efficacy of the entomopathogen B. bassiana, the fungus was genetically modified to express the Bacillus thuringiensis toxin Cyt2Ba. The mitotically stable transformant (Bb-Cyt2Ba) successfully expressed Cyt2Ba toxin, and the virulence of this strain against adults and larvae of Aedes aegypti and Aedes albopictus mosquitoes was significantly improved. In addition, egg laying was significantly affected by Bb-Cyt2Ba infection. Infection with this fungus resulted in a dramatic reduction in fecundity of the target mosquitoes. Therefore, this recombinant B. bassiana has great potential for use in mosquito control.
Introduction
Mosquito vectors transmit many diseases to humans and animals, causing illness and death that result in considerable socio-economic burdens in endemic countries [1]. Aedes mosquitoes (primarily Aedes aegypti and Aedes albopictus) are the primary vectors of dengue, Zika, chikungunya and yellow fever in tropical and subtropical zones, which have a devastating impact on human health [2, 3]. Vector control via chemical insecticides is a major method for vector-borne disease control, but the extensive use of chemical insecticides poses toxicity risks to humans as well as the environment and creates intensive pressure for mosquitoes to develop resistance [4].
Biological control agents such as entomopathogenic fungi are important alternatives or complements to chemical insecticides [5]. Many studies have shown the potential of entomopathogenic fungi, such as Beauveria bassiana, for the control of agricultural pests [6] and the vectors of human diseases, including mosquitoes [7]. One of the main advantages of using entomopathogenic fungi in insect control is that these fungi can infect all stages of the insects, including larvae and adults [8–10]. Furthermore, no cases of resistance of insects to entomopathogenic fungal infections have been reported to date [11]. However, the relatively slow action of fungal pathogens in killing vectors, compared with chemical insecticides, has hampered their widespread application in the field.
Genetic engineering is essential for introducing desirable traits into entomopathogenic fungi [12], which has resulted in a wide range of feasible types of genetic manipulation, from the expression of UV protectants, heat shock factors, immune modulators, cuticle-degrading enzymes and exogenous toxins to targeting insect vectors, disease transmission, and even arthropod behaviors [12]. It has been reported that transgenic B. bassiana expressing Ae. aegypti trypsin modulating oostatic factor (TMOF) exhibited increased virulence against Anopheles gambiae compared with the wild type strain [13]. Our previous study also found that the expression of the insect-specific toxin scorpion neurotoxin AaIT in B. bassiana enhanced virulence against Ae. albopictus mosquitoes [14]. The virulence of B. bassiana for mosquitoes could be increased via the expression of insecticidal toxins.
Bacillus thuringiensis (Bt), an entomopathogenic bacterium, is also an important bioinsecticide used for control of insects, including mosquitoes [15]. Based on the last updated data in the especial database for Bt toxins (June 2018), about 323 holotype toxins have been identified and characterized in the Bt strains isolated from different regions of the world [16]. The cytolytic δ-endotoxin (Cyt2Ba) containing 263 amino acids is found at very low concentrations in Bt crystals [17]. It has been reported that Cyt2Ba is toxic to Culex, Aedes and Anopheles larvae [18, 19]. In our study, the Cyt2Ba gene was introduced into the B. bassiana genome by genetic engineering to improve fungal virulence. We measured the virulence of this recombinant B. bassiana to the adults and larvae of Aedes mosquitoes (Ae. aegypti and Ae. albopictus). The effect of this strain on mosquito fecundity was also determined.
Methods
Ethics statement
Our only experimental animals are Aedes aegypti and Aedes albopictus, which do not involve animal ethical issues.
Mosquitoes
The Guangdong Provincial Center for Disease Control and Prevention collected Ae. albopictus and Ae. aegypti mosquitoes from different sites in the cities of Foshan and Zhanjiang in Guangdong Province. All mosquitoes were reared in standard insectary conditions at (28 ± 1) °C and (80 ± 5) % relative humidity with a light:dark cycle of 16 h:8 h. The larvae were fed daily with turtle food (Shenzhen INCH-GOLD Fish Food,.LTD, Shenzhen, CHA). Mosquito adults were provided with 10% glucose solution ad libitum. All collection was done on public land.
Microbial strains and media
The B. bassiana GIM3.428 strain (wild type) was purchased from the Guangdong Microbiology Culture Center and maintained on Czapek’s agar (CDA) at 4°C for preservation. Conidia were obtained by growing the fungus on CDA for 7 days at 25°C. Blastospores were obtained by the growth of the fungus in Sabouraud dextrose broth for 48 h and glucose-mineral medium for 24 h at 25°C under 120 rpm on a rotatory shaker.
Gene synthesis and vector construction
The coding sequence of Cyt2Ba (GenBank: GQ919041.1) was synthesized (Generay Biotech, Shanghai, CHA) with the B. bassiana preferred coding usage and cloned between the BamHI and EcoRI sites of pBARGPE1 to generate the plasmid pBARGPE1-Cyt2Ba. This plasmid retains a strong gpdA promoter to drive the insert’s gene expression and has the phosphinothricin (PPT) resistance gene (Bar) as a selectable marker for fungal transformation.
Fungal transformation
The plasmid pBARGPE1-Cyt2Ba was linearized with ScaI and then transformed into B.bassiana blastospores by electroporation as described previously [14]. Transformants were grown on CDA plates containing 150 μg/ml PPT at 25°C. After single spore isolation and subsequent subculturing for three generations on CDA with 150 μg/ml PPT at 25°C (7 days each generation), the putative transformants were verified by polymerase chain reaction (PCR) using primers for the bar gene (Bar-F, TCGTCAACCACTACATCGAGAC and Bar-R, GAAGTCCAGCTGCCAGAAAC) and Cyt2Ba gene (Cyt-F TATGGATCCGCCACCATGGAAC, and Cyt-R, TATGAATTCCTAGGACTTGATGGG). Furthermore, to verify the mitotic stability of their PPT resistance, the recombinants were subcultured for three generations on CDA without PPT at 25°C, and finally, they were subcultured on CDA with 400 μg/ml PPT at 25°C. Then, the transformants were analyzed by PCR. A stable transformant named Bb-Cyt2Ba was selected for the subsequent experiments.
Identification of Cyt2Ba expression in Bb-Cyt2Ba
The wild type (WT) and Bb-Cyt2Ba strains were grown on CDA for 4 days. The conidia were collected with cotton swabs. Mosquitoes were infected by contact with WT or Bb-Cyt2Ba conidia on the swab. Dead female adult Ae. albopictus mosquitoes were maintained at 25°C under saturated humidity for 4 days. To verify the transcription of the Cyt2Ba gene, total RNA was extracted from the CDA culture supernatant or infected mosquitoes by using an RNeasy mini plant kit (Qiagen, Duesseldorf, GER). Reverse-transcription PCR (RT-PCR) was performed using the primer pair Cyt-F and Cyt-R.
The expression of Cyt2Ba was detected by western blot analyses. Cyt2Ba polyclonal antibodies were raised in rabbits (BGI Genomics, Shenzhen, CHA), and an alkaline phosphatase-conjugated anti-rabbit IgG secondary antibody (Santa Cruz Biotech, Newport, USA) was used for detection. The total proteins were extracted from the CDA culture supernatant and the infected mosquitoes as previously described (14). Fifty micrograms of each sample was separated on a 12% polyacrylamide gel by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis, and western blotting was then performed.
Survival assays
B. bassiana strains were grown and maintained on CDA at 25°C. Conidial suspensions in 0.02% (vol/vol) Tween 80 were prepared from 7-d-old cultures. To conduct fungal infection, adult female Aedes mosquitoes were transferred to the filter (placed on a 300 ml plastic cup covered with a net), which had absorbed 10 ml of conidial suspension at 1 × 106 conidia/ml (low), 1 × 107 conidia/ml (middle) or 1 × 108 conidia/ml (high) or 0.02% Tween 80 (control) for 3 h. Then, the mosquitoes were transferred separately to different plastic containers (30 mosquitoes/cup). The contaminated or control mosquitoes were maintained on a 10% glucose diet in plastic containers at 28°C. The dead adult mosquitoes in each treatment group were counted and removed every 12 h until the last mosquito died. The dead mosquitoes were washed twice in phosphate-buffered saline and placed in humid filter papers for conidiation. To infect the larvae, conidial suspensions of 1 × 105 conidia/ml (low), 1 × 106 conidia/ml (middle) and 1 × 107 conidia/ml (high) of B. bassiana were added to the cups containing 30 second-instar Aedes larvae in 30 ml of double-distilled water (ddH2O). Thirty individuals in ddH2O without fungi were used as the control. The larvae were provided with turtle food at a rate of 0.2–0.3 mg/larva per day and maintained at 28°C. The larvae were monitored every 12 h for survival (the percentage surviving) until day 10. Each treatment for the larvae or adults contained 90 (30 × 3) mosquitoes. The survival of the adults or larvae in each group was calculated every day. The bioassay was repeated three times for statistical analysis.
The effects of wild type or recombinant fungus infection on mosquito fecundity
To examine the effect of fungal infection on the fecundity of mosquitoes, Aedes females were infected by contact with the filter paper that had absorbed 10 ml of the conidial suspension with 1 × 108 conidia/ml of the wild type or Bb-Cyt2Ba strain. After fungal infection, the females were fed with defibrinated sheep blood for 1 h. Then, the engorged mosquitoes were placed individually into a 250-ml, gauze-covered paper cup containing a small amount of water and funnel-shaped filter paper to serve as a repository for the eggs. The eggs of each mosquito were counted one week after blood feeding. Sixty female mosquitoes per treatment were used to assess the impact of fungal infection on fecundity.
Statistical analysis
For survival assays, data were analyzed using Probit and Kaplan–Meier survival tests; a log-rank test was used to assess the equality of survival distributions during the Kaplan–Meier analysis. Furthermore, cross-tabulation analyses using Pearson’s chi-square test were applied to compare the percentages of ovipositing females among the different groups. In addition, Mann-Whitney tests were applied to compare the fecundity among the groups. All analyses were performed with SPSS (v. 20.0), and significance was defined by P<0.05.
Results
The Cyt2Ba gene was stably inherited in the Bb-Cyt2Ba strain
Transformation of the competent blastopores of B. bassiana with linearized plasmid pBARGPE1-Cyt2Ba produced one transgenic colony on the CDA plate containing 150 μg/ml PPT. The transformant was able to grow on a CDA plate containing 150 μg/ml PPT for three generations. Then, after three rounds of subculturing on PPT-free CDA plates, the transformant was capable of growing on the CDA plate containing 400 μg/ml PPT. The expected PCR fragments from all the Bb-Cyt2Ba samples appeared on the agarose gel, but not the WT (S1 Fig), which confirmed the consistent heredity of the Cyt2Ba gene in the Bb-Cyt2Ba genome. Transformation of the pBARGPE1-Cyt2Ba construct into B. bassiana did not affect the germination rate of the fungus after 24 h, and we did not find any morphological differences between the germ tubes of WT and Bb-Cyt2Ba.
Cyt2Ba toxin was stably expressed in the Bb-Cyt2Ba strain
The WT and Bb-Cyt2Ba strains were harvested from the CDA culture after incubation for 4 days at 25°C. The fungal outgrowths were those of a typical B. bassiana, and they appeared on the dead female Aedes mosquitoes that were infected through cuticle penetration after being maintained at 25°C in saturated humidity for 4 days. RT-PCR and western blot analyses confirmed that the recombinant strain expressed the Cyt2Ba toxin stably, but not the WT strain (Fig 1).
Fig 1. Evidence for Cyt2Ba expression in the Bb-Cyt2Ba strain.
(A) RT-PCR detection of Cyt2Ba gene transcription in Bb-Cyt2Ba collected from the infected dead female Ae. albopictus mosquitoes and the CDA with positive results and in the WT control with negative results. The 18S rRNA gene was detected for the loading control. (B) Western blot detection of Cyt2Ba expression in Bb-Cyt2Ba and the WT with a polyclonal antibody against Cyt2Ba from different samples. Lane 1, culture supernatant from Bb-Cyt2Ba grown in CDA for 4 days with a positive result; Lane 2, culture supernatant from WT grown in CDA for 4 days with a negative result; and Lane 3, the dead female Ae. albopictus mosquitoes infected by Bb-Cyt2Ba and incubated at 25°C for another 4 days; Lane 4, the dead female mosquitoes infected by the WT and incubated at 25°C for another 4 days; Lane 5, loading control.
The survival of mosquitoes was reduced by Bb-Cyt2Ba infection
The mosquito mortalities generally increased with the elevated conidial concentration and prolonged post-treatment time for both Bb-Cyt2Ba and Bb-WT (Figs 2 and 3). Significant differences were found among the groups treated with different concentrations of Bb-Cyt2Ba or the Bb-WT (S1 Table). In addition, significant differences were found between the mortalities of Bb-Cyt2Ba and the WT-treated Aedes adults at each concentration (S2 Table). Thus, the adult mosquitoes that were treated with Bb-Cyt2Ba tended to die faster than those treated with the WT at the same concentration (Fig 2), and the difference was significant (S2 Table). Similarly, except for Ae. aegypti larvae infected with fungi at the low concentration, Bb-Cyt2Ba-treated larvae tended to die faster than those treated with the WT at each concentration (Fig 3), and the difference was significant (S2 Table).
Fig 2. Survival curves of the adult mosquitoes for different Bb-Cyt2Ba and WT treatments.
The survival curves of Ae. aegypti (A) and Ae. albopictus (B) females when treated with (C1) 1 × 106, (C2) 1 × 107 and (C3) 1 × 108 conidia/ml suspensions of Bb-Cyt2Ba and WT. Each treatment contained 90 mosquitoes, performed three times.
Fig 3. Survival curves of the mosquito larvae for different Bb-Cyt2Ba and WT treatments.
The survival curves of Ae. aegypti (A) and Ae. albopictus (B) females when treated with (C1) 1 × 105, (C2) 1 × 106 and (C3) 1 × 107 conidia/ml suspensions of Bb-Cyt2Ba and WT. Each treatment contained 90 larvae, performed three times. The LT50s of the female Ae. aegypti for Bb-Cyt2Ba treatment were reduced by 33%, 19% and 47% compared with those for WT treatment at the high, middle and low concentrations, respectively (Table 1). Moreover, the LT50s of Ae. albopictus adults for Bb-Cyt2Ba treatment were reduced by 20%, 23% and 29% at these three concentrations compared with those for WT treatment. In addition, compared with the WT, the LT50 of the Bb-Cyt2Ba infection was reduced by 42% and 25% for Ae. aegypti larvae and 33% and 31% for Ae. albopictus larvae at the high and middle concentrations, respectively (Table 1). These results indicated that the expressed Cyt2Ba toxin in the fungus reduced the survival of the tested larvae and adult mosquitoes.
Table 1. The median lethal times (LT50s) of the fungal strains Bb-Cyt2Ba and WT against Aedes mosquitoes (larvae or adults) at three concentrations.
| Mosquitoes | Fungal strains | LT50 (± standard error), day | ||
|---|---|---|---|---|
| (conidia/ml) | 1 x 108 | 1 x 107 | 1 x 106 | |
| Ae. aegypti adults | Bb-Cyt2Ba | 4.0 (±0.2) | 6.5 (±0.2) | 8.5 (±0.3) |
| WT | 6.0 (±0.1) | 8.0 (±0.5) | 16.0 (±1.3) | |
| Ae. aegypti larvae | Bb-Cyt2Ba | 3.5 (±0.3) | 6.0 (±0.7) | |
| WT | 6.0 (±0.2) | 8.0 (±0.5) | ||
| Ae. albopictus adults | Bb-Cyt2Ba | 4.0 (±0.3) | 5.0 (±0.3) | 10.0 (±0.5) |
| WT | 5.0 (±0.3) | 6.5 (±0.3) | 14.0 (±1.7) | |
| Ae. albopictus larvae | Bb-Cyt2Ba | 4.0 (±0.1) | 5.5 (±0.1) | |
| WT | 6.0 (±0.3) | 8.0 (±0.3) | ||
The difference in the LT50 between the Bb-Cyt2Ba and the WT strains at each concentration shown above is significant.
The fecundity of female mosquitoes was reduced by Bb-Cyt2Ba infection
Egg laying was significantly affected by fungal infection. The percentage of Bb-Cyt2Ba-infected Ae. aegypti females that oviposited within 7 days after a blood meal was only 45% (27/60), which was significantly lower compared to that of the WT (65%, 39/60) and the control (95%, 57/60) (S3 Table). Similarly, the percentage of Ae. albopictus mosquitoes producing eggs was 50% (30/60), which was significantly lower than that of the WT (70%, 42/60) and the control (97%, 58/60) (S3 Table).
The mean number of eggs produced per female within 7 days for Ae. aegypti was 33.9 (95% CI: 29.2–38.6) in the Bb-Cyt2Ba-treated group, 47.8 (95% CI: 42.5–53.1) in the WT-treated group and 76.4 (95% CI: 68.4–84.4) in the control group (Fig 4A). For Ae. albopictus mosquitoes, the mean number of eggs produced per female was 37.3 (95% CI: 31.8–42.8) in the Bb-Cyt2Ba-treated group, 53.3 (95% CI: 48.2–58.4) in the WT-treated group and 72.6 (95% CI: 64.3–81.0) in the control group (Fig 4B). Thus, infection of mosquitoes with the wild type strain resulted in a significant reduction (37% for Ae. aegypti and 27% for Ae. albopictus) in fecundity compared to noninfected controls. However, expression of Cyt2Ba toxin in the fungi resulted in a dramatic reduction (56% for Ae. aegypti, 49% for Ae. albopictus) in fecundity compared to the controls.
Fig 4. Effects of Bb-Cyt2Ba infection on mosquito reproduction.
Ae. aegypti (A) and Ae. albopictus (B) females infected with a suspension of 1 × 108 conidia/ml of the WT or Bb-Cyt2Ba strain were fed a blood meal 3 h after fungal infection. Noninfected, blood-fed mosquitoes were used as controls. Each bar represents the mean of eggs per mosquito. Mann-Whitney tests were used. Error bars indicate ± standard error (SE).
Discussion
The slow action of insect-pathogenic fungi on target pests is one of the limitations to their commercialization and large-scale application as biocontrol agents [4]. Some studies have shown that the insect-killing efficacy of B. bassiana is considerably improved by recombination with the exogenous Ae. aegypti TMOF gene, scorpion neurotoxin AaIT gene [8, 20], cuticle degradation protease PR1A gene [21], or vegetative insecticidal proteins of Bacillus thuringiensis (Bt) [22].
Cytolytic (Cyt) toxins are produced by a minor group of Bt, mostly in subspecies that are toxic to Dipteran insects [23, 24]. These toxins do not need a specific receptor but directly interact with membrane lipids and insert into the membrane to form pores [25–27] or destroy the membrane by a detergent-like interaction [28]. In our study, the cytolytic toxin Cyt2Ba gene was genetically introduced into the genome of the wild type of B. bassiana to enhance its virulence against mosquitoes. The mitotically stable transformant Bb-Cyt2Ba can successfully express this exogenous toxin, and the virulence of Bb-Cyt2Ba for Ae. aegypti and Ae. albopictus mosquitoes (including adults and larvae) was significantly increased compared with that of the WT.
When adult mosquitoes were infected by the fungus through cuticle contact, the fungus quickly invaded the mosquito tissues and cells. It has been reported that approximately 24 h was required for the fungus to penetrate the cuticle and reach the hemocoel of insects [29, 30]. In our study, the fungus may have released Cyt2Ba toxin into the mosquito hemocoel after penetration, which resulted in quicker death for the Aedes adult mosquitoes. Furthermore, it has been reported that when fungal spores are applied to an aquatic habitat, typical for mosquito larvae, the nutrients in the water are usually sufficient to stimulate the germination of the spores following water intake [31, 32]. For mosquito larvae, the main infection routes are through feeding and respiration [33]. The Cyt2Ba toxin is supposed to be delivered to the insect circulatory system after Bb-Cyt2Ba infects the mosquito larvae, which results in faster death of the larvae compared with the WT infection. The various commercial products of Bt have been used in the control of mosquito larvae. Formulations include a variety of granules, flowable concentrates, wettable powders, and slow-release tablets and briquettes [34]. The efficacy of Bt formulations has been demonstrated in a diversity of habitats against a multitude of species of mosquitoes [34]. Like Bt, the Bb-Cyt2Ba strain will increase its efficiency in mosquito larvae control with a suitable formulation, which is helpful to the development of Bb-Cyt2Ba strain as a commercial product.
In addition, the effects of Bb-Cyt2Ba and WT infection on mosquito fecundity were also assessed in our study. Bb-Cyt2Ba infection resulted in a dramatic reduction in the fecundity of target mosquitoes. Despite the LT50 of Bb-Cyt2Ba-infected mosquitoes suggesting that death was not quick enough to completely inhibit the females from going through their gonotrophic cycles, fecundity reduction might be a byproduct of rapid fungal invasion of Bb-Cyt2Ba, which is hypothesized to be an adaptive strategy of the host [35]. These data suggested that strain Bb-Cyt2Ba has the potential to reduce the size of Aedes mosquito populations by severely compromising fecundity.
Compared to our previous study, the virulence of Bb-Cyt2Ba to Ae. albopictus mosquitoes is a little bit higher than that of the B. bassiana expressing scorpion neurotoxin AaIT toxin [14]. Due to their high specificity against insects and low toxicity to vertebrates and plants of these proteins [36–38], AaIT and Cyt2Ba genes are both good choices for introduction into the genome of B. bassiana to increase the fungal pathogenicity.
Entomopathogenic fungi show considerable potential to be developed as biopesticides [39–41]. The production and application of fungi both involve relatively simple infrastructures and processes [40, 42], which can be readily adopted in mosquito-borne disease-endemic countries. However, before gene-modified fungi can be used and integrated into control programs, more data on the environmental safety, their effect on nontarget insect hosts and the possibility of gene flow are required.
In conclusion, our data showed that expression of the Bacillus thuringiensis toxin Cyt2Ba in B. bassiana increased its effectiveness against two important mosquito vectors, Ae. aegypti and Ae. albopictus. The median lethal times were shorter in the mosquito adult and larval groups infected with the Bb-Cyt2Ba strain compared with the groups infected with the wild type strain. In addition, the fecundity of the females was dramatically reduced by Bb-Cyt2Ba infection compared with WT infection. This recombinant B. bassiana strain Bb-Cyt2Ba was valuable in development as a bioinsecticide for mosquito control and even for other types of pest control.
Supporting information
Conventional PCR was performed for the bar (A) and Cyt2Ba (B) genes with the genomic DNA of the different generations of the transformant Bb-Cyt2Ba and the WT. M, DNA maker; lane 1, the positive control; lane 2, the negative control (WT); lanes 3–5, the transformants that were subcultured for 1 to 3 generations on CDA with 150 μg/ml PPT; lane 6, the transformants subcultured on CDA with 400 μg/ml PPT.
(TIF)
(DOCX)
(DOCX)
(DOCX)
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
Funding Statement
This research was supported by National Key R&D Program of China (2017YFD0500400), National Natural Science Foundation of China (81772217, 20180907, 81572012), Guangdong Provincial Natural Science Foundation Project (2016A030311025, 2017A030313694), Science and Technology Planning Project of Guangdong Province (2018A050506038), and Key project of Guangzhou science research (201904020011) to HJP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Ferguson NM. Challenges and opportunities in controlling mosquito-borne infections. Nature. 2018;559(7715):490–7. 10.1038/s41586-018-0318-5 [DOI] [PubMed] [Google Scholar]
- 2.Souza-Neto JA, Powell JR, Bonizzoni M. Aedes aegypti vector competence studies: A review. Infect Genet Evol. 2018;67:191–209. 10.1016/j.meegid.2018.11.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Estep AS, Sanscrainte ND, Waits CM, Bernard SJ, Lloyd AM, Lucas KJ, et al. Quantification of permethrin resistance and kdr alleles in Florida strains of Aedes aegypti (L.) and Aedes albopictus (Skuse). PLoS Negl Trop Dis. 2018;12(10):e0006544 10.1371/journal.pntd.0006544 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Wei G, Lai Y, Wang G, Chen H, Li F, Wang S. Insect pathogenic fungus interacts with the gut microbiota to accelerate mosquito mortality. Proc Natl Acad Sci U S A. 2017;114(23):5994–9. 10.1073/pnas.1703546114 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Yanhua F, Dov B, Chloe H, Almudena OU, Keyhani NO. Exploiting host molecules to augment mycoinsecticide virulence. Nat Biotechnol. 2012;30(1):35 10.1038/nbt.2080 [DOI] [PubMed] [Google Scholar]
- 6.Lord JC. From Metchnikoff to Monsanto and beyond: the path of microbial control. J Invertebr Pathol. 2005;89(1):19–29. 10.1016/j.jip.2005.04.006 [DOI] [PubMed] [Google Scholar]
- 7.Scholte EJ, Knols BG, Samson RA, Takken W. Entomopathogenic fungi for mosquito control: a review. J Insect Sci. 2004;4:19 10.1093/jis/4.1.19 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Deng SQ, Huang Q, Wei HX, Zhou LJ, Yao Lj, Li DL, et al. Beauveria bassiana infection reduces the vectorial capacity of Aedes albopictus for the Zika virus. J Pest Sci. 2019;92:781–9. [Google Scholar]
- 9.Pereira CR, Paula ARD, Gomes SA, Pedra PCO Jr, Samuels RI. The potential of Metarhizium anisopliae and Beauveria bassiana isolates for the control of Aedes aegypti (Diptera: Culicidae) larvae. Biocontrol Sci Tech. 2009;19(8):881–6. [Google Scholar]
- 10.de Paula AR, Brito ES, Pereira CR, Carrera MP, Samuels RI. Susceptibility of adult Aedes aegypti (Diptera: Culicidae) to infection by Metarhizium anisopliae and Beauveria bassiana: prospects for Dengue vector control. Biocontrol Sci Tech. 2008;18(10):1017–25. [Google Scholar]
- 11.Paula AR, Silva LEI, Ribeiro A, Butt TM, Silva CP, Samuels RI. Improving the delivery and efficiency of fungus-impregnated cloths for control of adult Aedes aegypti using a synthetic attractive lure. Parasit Vectors. 2018;11(1):285 10.1186/s13071-018-2871-z [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Ortiz-Urquiza A, Luo Z, Keyhani NO. Improving mycoinsecticides for insect biological control. Appl Microbiol Biotechnol. 2015;99(3):1057–68. 10.1007/s00253-014-6270-x [DOI] [PubMed] [Google Scholar]
- 13.Kamareddine L, Fan Y, Osta MA, Keyhani NO. Expression of trypsin modulating oostatic factor (TMOF) in an entomopathogenic fungus increases its virulence towards Anopheles gambiae and reduces fecundity in the target mosquito. Parasit Vectors. 2013;6:22 10.1186/1756-3305-6-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Deng SQ, Cai QD, Deng MZ, Huang Q, Peng HJ. Scorpion neurotoxin AaIT-expressing Beauveria bassiana enhances the virulence against Aedes albopictus mosquitoes. AMB Express. 2017;7(1):121 10.1186/s13568-017-0422-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Jouzani GS, Valijanian E, Sharafi R. Bacillus thuringiensis: a successful insecticide with new environmental features and tidings. Appl Microbiol Biotechnol. 2017;101(7):2691–711. 10.1007/s00253-017-8175-y [DOI] [PubMed] [Google Scholar]
- 16.Crickmore N BJ, Bravo A, Lereclus D, Narva K, Sampson K, et al. "Bacillus thuringiensis toxin nomenclature" (2018) http://www.btnomenclature.info/ [Google Scholar]
- 17.Guerchicoff A, Ugalde RA, Rubinstein CP. Identification and characterization of a previously undescribed cyt gene in Bacillus thuringiensis subsp. israelensis. Appl Environ Microb. 1997;63(7):2716–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Ben-Dov E. Bacillus thuringiensis subsp. israelensis and its dipteran-specific toxins. Toxins. 2014;6(4):1222–43. 10.3390/toxins6041222 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Deng SQ, Deng MZ, Chen JT, Zheng LL, Peng HJ. [Larvicidal activity of recombinant Escherichia coli expressing scorpion neurotoxin AaIT or B.t.i toxin Cyt2Ba against mosquito larvae and formulations for enhancing the effects]. Journal of Southern Medical University. 2017;37(6):750–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Wang C, St Leger RJ. A scorpion neurotoxin increases the potency of a fungal insecticide. Nat Biotech. 2007;25(12):1455–6. [DOI] [PubMed] [Google Scholar]
- 21.Lu D, Pava-Ripoll M, Li Z, Wang C. Insecticidal evaluation of Beauveria bassiana engineered to express a scorpion neurotoxin and a cuticle degrading protease. Appl Microbiol Biotechnol. 2008;81(3):515–22. 10.1007/s00253-008-1695-8 [DOI] [PubMed] [Google Scholar]
- 22.Qin Y, Ying SH, Chen Y, Shen ZC, Feng MG. Integration of insecticidal protein Vip3Aa1 into Beauveria bassiana enhances fungal virulence to Spodoptera litura larvae by cuticle and per Os infection. Appl Environ Microb. 2010;76(14):4611–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Juarez-Perez V, Guerchicoff A, Rubinstein C, Delecluse A. Characterization of Cyt2Bc toxin from Bacillus thuringiensis subsp. medellin. Appl Environ Microb. 2002;68(3):1228–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Promdonkoy B, Chewawiwat N, Tanapongpipat S, Luxananil P, Panyim S. Cloning and characterization of a cytolytic and mosquito larvicidal delta-endotoxin from Bacillus thuringiensis subsp. darmstadiensis. Curr Microbiol. 2003;46(2):94–8. 10.1007/s00284-002-3823-5 [DOI] [PubMed] [Google Scholar]
- 25.Promdonkoy B, Ellar DJ. Investigation of the pore-forming mechanism of a cytolytic delta-endotoxin from Bacillus thuringiensis. Biochem J. 2003;374(Pt 1):255–9. 10.1042/BJ20030437 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Thomas WE, Ellar DJ. Mechanism of action of Bacillus thuringiensis var israelensis insecticidal delta-endotoxin. FEBS Lett. 1983;154(2):362–8. 10.1016/0014-5793(83)80183-5 [DOI] [PubMed] [Google Scholar]
- 27.Bravo A, Gill SS, Soberon M. Mode of action of Bacillus thuringiensis Cry and Cyt toxins and their potential for insect control. Toxicon. 2007;49(4):423–35. 10.1016/j.toxicon.2006.11.022 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Butko P. Cytolytic toxin Cyt1A and its mechanism of membrane damage: data and hypotheses. Appl Environ Microb. 2003;69(5):2415–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Jaronski ST. Ecological factors in the inundative use of fungal entomopathogens. BioControl. 2010;55(1):159–85. [Google Scholar]
- 30.Padilla-Guerrero IE, Barelli L, Gonzalez-Hernandez GA, Torres-Guzman JC, Bidochka MJ. Flexible metabolism in Metarhizium anisopliae and Beauveria bassiana: role of the glyoxylate cycle during insect pathogenesis. Microbiology. 2011;157(Pt 1):199–208. 10.1099/mic.0.042697-0 [DOI] [PubMed] [Google Scholar]
- 31.Farenhorst M, Hilhorst A, Thomas MB, Knols BG. Development of fungal applications on netting substrates for malaria vector control. J Med Entomol. 2011;48(2):305–13. 10.1603/me10134 [DOI] [PubMed] [Google Scholar]
- 32.Hegedus DD, Khachatourians GG. The impact of biotechnology on hyphomycetous fungal insect biocontrol agents. Biotechnol Adv. 1995;13(3):455–90. [DOI] [PubMed] [Google Scholar]
- 33.Morleydavies J, Moore D, Prior C. Screening of Metarhizium and Beauveria spp. conidia with exposure to simulated sunlight and a range of temperatures. Mycological research. 1996;100(1):31–8. [Google Scholar]
- 34.Lacey LA. Bacillus thuringiensis serovariety israelensis and Bacillus sphaericus for mosquito control. J Am Msquito Contr. 2007;23(2 Suppl):133–63. [DOI] [PubMed] [Google Scholar]
- 35.Hurd H. Host fecundity reduction: a strategy for damage limitation? Trends Parasitol. 2001;17(8):363–8. [DOI] [PubMed] [Google Scholar]
- 36.Gurevitz M, Karbat I, Cohen L, Ilan N, Kahn R, Turkov M, et al. The insecticidal potential of scorpion beta-toxins. Toxicon. 2007;49(4):473–89. 10.1016/j.toxicon.2006.11.015 [DOI] [PubMed] [Google Scholar]
- 37.Crickmore N. Beyond the spore-past and future developments of Bacillus thuringiensis as a biopesticide. J Appl Microbiol. 2006;101(3):616–9. 10.1111/j.1365-2672.2006.02936.x [DOI] [PubMed] [Google Scholar]
- 38.Teixeira Correa RF, Ardisson-Araujo DM, Monnerat RG, Ribeiro BM. Cytotoxicity analysis of three Bacillus thuringiensis subsp. israelensis delta-endotoxins towards insect and mammalian cells. PloS one. 2012;7(9):e46121 10.1371/journal.pone.0046121 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Scholte EJ, Ng'habi K, Kihonda J, Takken W, Paaijmans K, Abdulla S, et al. An entomopathogenic fungus for control of adult African malaria mosquitoes. Science. 2005;308(5728):1641–2. 10.1126/science.1108639 [DOI] [PubMed] [Google Scholar]
- 40.Zimmermann G. The entomopathogenic fungus Metarhizium anisopliae and its potential as a biocontrol agent. Pest Manag Sci. 2010;37(4):375–9. [Google Scholar]
- 41.Dong Y, Morton JC Jr., Ramirez JL, Souza-Neto JA, Dimopoulos G. The entomopathogenic fungus Beauveria bassiana activate toll and JAK-STAT pathway-controlled effector genes and anti-dengue activity in Aedes aegypti. Insect Biochem Molec. 2012;42(2):126–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Strasser H, Butt TVA. Are there any risks in using entomopathogenic fungi for pest control, with particular reference to the bioactive metabolites of Metarhizium, Tolypocladium and Beauveria species? [Review]. Biocontrol Sci Tech. 2000;10(6):717–35. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Conventional PCR was performed for the bar (A) and Cyt2Ba (B) genes with the genomic DNA of the different generations of the transformant Bb-Cyt2Ba and the WT. M, DNA maker; lane 1, the positive control; lane 2, the negative control (WT); lanes 3–5, the transformants that were subcultured for 1 to 3 generations on CDA with 150 μg/ml PPT; lane 6, the transformants subcultured on CDA with 400 μg/ml PPT.
(TIF)
(DOCX)
(DOCX)
(DOCX)
Data Availability Statement
All relevant data are within the manuscript and its Supporting Information files.